Status:
COMPLETED
A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®
Lead Sponsor:
Bayer
Conditions:
Carcinoma, Renal Cell
Carcinoma, Renal Cell (Advanced)
Eligibility:
All Genders
18+ years
Brief Summary
Evaluation of the efficacy and safety of Nexavar ® in advanced Renal Cell Carcinoma (RCC) and calculation of related medical costs.
Eligibility Criteria
Inclusion
- Patients with diagnosis of advanced RCC and decision taken by the investigator to prescribe Nexavar®. The patients should have sufficient knowledge of French or Dutch to be able to participate in the Study
Exclusion
- Exclusion criteria must be read in conjunction with the Belgian product information
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00771147
Start Date
June 1 2008
End Date
November 1 2010
Last Update
June 15 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Belgium